Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Transchem Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Option Chain
Analyzes market sentiment, predicts Transchem Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Transchem L - Letter Sent To Members
-
Transchem L - Reg. 34 (1) Annual Report.
-
Transchem L - Notice Of 48Th Annual General Meeting ('AGM') Of Members Of\r\nThe Company And Annual Report For The Financial
-
Transchem L - Board Meeting Intimation for Approval Of Un-Audited Financial Results Of The Company For The Quarter Ended June
-
Transchem L has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025
-
Transchem L - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Transchem L - Intimation Of Book Closure Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requirements)
-
Transchem L - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Transchem L - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Transchem L - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of The SEBI (Listing Obligatio
-
Transchem L - Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors
-
Transchem L Q4 net profit down 41.60% at Rs 0.73 cr
-
Transchem L - RE-APPOINTMENT OF INTERNAL AUDITOR AND APPOINTMENT OF SECRETARIAL AUDITOR
-
Transchem L - Audited Financial Results For The Quarter And Year Ended March 31, 2025.
-
Transchem L - Board Meeting Outcome for Outcome Of Board Meeting Pursuant To Regulation 30 Of SEBI Listing Regulations, 2015
-
Transchem L - Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended March 31, 2025
-
Transchem L - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Key fundamentals
Evaluate the intrinsic value of Transchem Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 79.3154 | 75.646 | 65.8422 | 66.3004 | 62.9414 |
| Liabilities | 79.3154 | 75.646 | 65.8422 | 66.3004 | 62.9414 |
| Equity | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 |
| Gross Profit | -1.4639 | -1.7358 | -1.732 | -2.7444 | 20.5219 |
| Net Profit | 5.2259 | 4.2034 | 1.2371 | 2.8682 | 24.1501 |
| Cash From Operating Activities | 36.0003 | -39.3063 | 1.2192 | 21.9093 | -27.7193 |
| NPM(%) | 198.67 | 1025.21 | 0 | 0 | 107.53 |
| Revenue | 2.6304 | 0.41 | 0 | 0 | 22.4589 |
| Expenses | 4.0943 | 2.1458 | 1.732 | 2.7444 | 1.937 |
| ROE(%) | 6.58 | 5.29 | 1.55 | 3.61 | 30.44 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 10 Sep 2001 | 0 | 0 | 0 | 3.8 |
Peers
Other companies within the same industry or sector that are comparable to Transchem Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 878.25 | -1.44 | 29.14 | 24.27 | 301.39 | 0.57 |
| Lotus Eye Hospital and Institute Ltd | 72.49 | -1.28 | 207.11 | 88.45 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 12.70 | 2.92 | 211.67 | 45.59 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 879.50 | -2.96 | 0.00 | 83.41 | -601.21 | 0.00 |
Company Info
Transchem Ltd. was incorporated as a Private Limited Company on November 11, 1976 and converted into a Public Limited Company on April 13, 1992. The Company is engaged in the manufacture of Bulk Drugs at its factory at Ambernath. District Thane, Maharashtra. The Bulk Drugs manufactured by the Company are high value added products like Frusemide IP/BP and Fenbendazole with a installed capacity of 6000 Kg.p.a. and 3600 Kg. p.a. respectively. The Company is promoted by Chemitex Corporation established Pharmaceutical marketing Company, in association with Shri Rajen Desai Chemitex Corporation has been engaged in the field by chemicals and pharmaceutical items for the last 15 years. 2002-T ranschem Ltd has informed that the Board of Directors have accepted the resignation of Mr Mukesh Garach, an Independent Director. Mr Rajendra Shetty has joined the Board as Additional Director. 2008 -E-mail ID for Investors Complaints:transchem422@yahoo.co.in 2014 -Transchem Ltd has Mr. Vinayak G Vengurlekar as additional director and Mr. Vinayak G Vengurlekar is an independent director of the company.
Transchem Ltd. was incorporated as a Private Limited Company on November 11, 1976 and converted into a Public Limited Company on April 13, 1992. The Company is engaged in the manufacture of Bulk Drugs at its factory at Ambernath. District Thane, Maharashtra. The Bulk Drugs manufactured by the Company are high value added products like Frusemide IP/BP and Fenbendazole with a installed capacity of 6000 Kg.p.a. and 3600 Kg. p.a. respectively. The Company is promoted by Chemitex Corporation established Pharmaceutical marketing Company, in association with Shri Rajen Desai Chemitex Corporation has been engaged in the field by chemicals and pharmaceutical items for the last 15 years. 2002-T ranschem Ltd has informed that the Board of Directors have accepted the resignation of Mr Mukesh Garach, an Independent Director. Mr Rajendra Shetty has joined the Board as Additional Director. 2008 -E-mail ID for Investors Complaints:transchem422@yahoo.co.in 2014 -Transchem Ltd has Mr. Vinayak G Vengurlekar as additional director and Mr. Vinayak G Vengurlekar is an independent director of the company.
Read More
Parent Organisation
Transchem Ltd.
Founded
18/11/1976
Managing Director
NSE Symbol
TRANSCHEMEQ
FAQ
The current price of Transchem Ltd is
The 52-week high for Transchem Ltd is
The market capitalization of Transchem Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Transchem Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Transchem Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Transchem Ltd shares.
The CEO of Transchem Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
